Valencia Technologies
Valencia, US · Founded 2014 · Delaware corporation · 1 known investors
Valencia Technologies is a neuromodulation company that makes eCoin, an FDA-approved coin-sized tibial nerve implant for treating Urge Urinary Incontinence. The leadless neurostimulator is placed under the skin near the ankle in a minimally invasive procedure to provide drug-free bladder control therapy for patients.
Founders & leadership
Valencia Technologies was founded in 2014 by Jeff Greiner.
JG
Jeff GreinerinFounder & Board Member
SG
Stacy Greiner ChamblissExecutive
JS
Jim SurekinCEO and Board Member
SO
Stacy O'Connell GreinerCorporate Secretary
Board
KG
Kim GreinerBoard director
Investors · 1
Funding
SEC filings, press & company announcements$54.1M disclosed across 9 rounds · 2013–2025
- $35MraisedFeb 2025 · 2 sourcesSource ↗
▶$1.9MraisedMar 2020 · 13 investors · Other Health CareRule 506(b)
▶$1.9MraisedMar 2020 · 13 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Jeffrey GreinerExecutive Officer, Director
- Stacy ChamblissExecutive Officer
- David K.L. PetersonDirector
- James CrinesDirector
- Offering amount
- $2M
- Amount sold
- $1.9M
- Minimum investment
- $50K
- First sale
- Dec 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2.4MraisedMar 2020 · 17 investors · Other Health CareRule 506(b)
▶$2.4MraisedMar 2020 · 17 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Jeffrey GreinerExecutive Officer, Director
- Stacy ChamblissExecutive Officer
- James CrinesDirector
- David K.L. PetersonDirector
- Offering amount
- $2.4M
- Amount sold
- $2.4M
- Minimum investment
- $20K
- First sale
- Aug 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2.4MraisedMar 2020 · 12 investors · Other Health CareRule 506(b)
▶$2.4MraisedMar 2020 · 12 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Jeffrey GreinerExecutive Officer, Director
- Stacy ChamblissExecutive Officer
- David K.L. PetersonDirector
- James CrinesDirector
- Eve KurtinDirector
- Offering amount
- $2.4M
- Amount sold
- $2.4M
- Minimum investment
- $50K
- First sale
- Jan 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$4.2MraisedMar 2020 · 28 investors · Other Health CareRule 506(b)
▶$4.2MraisedMar 2020 · 28 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- David PetersonDirector
- James CrinesDirector
- Jeffrey GreinerExecutive Officer, Director
- Stacy ChamblissExecutive Officer
- Offering amount
- $4.2M
- Amount sold
- $4.2M
- Minimum investment
- $15K
- Proceeds to insiders
- $4.2M
- First sale
- Nov 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.5MraisedMar 2020 · 36 investors · Other Health CareRule 506(b)
▶$1.5MraisedMar 2020 · 36 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- James CrinesDirector
- Stacy ChamblissExecutive Officer
- Jeffrey GreinerExecutive Officer, Director
- David K.L. PetersonDirector
- Offering amount
- $1.5M
- Amount sold
- $1.5M
- Minimum investment
- $5K
- Proceeds to insiders
- $1.5M
- First sale
- Jan 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.9MraisedMar 2017 · 23 investors · Other Health CareRule 506(b)
▶$1.9MraisedMar 2017 · 23 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- David K.L. PetersonDirector
- James CrinesDirector
- Stacy ChamblissExecutive Officer
- Jeff GreinerExecutive Officer, Director
- Offering amount
- $2M
- Amount sold
- $1.9M
- Minimum investment
- $25K
- First sale
- Dec 2016
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
▶$2.2MraisedMar 2015 · 18 investors · Other Health CareRule 506(c)
▶$2.2MraisedMar 2015 · 18 investors · Other Health Care
Rule 506(c)Officers, directors & promoters on the filing
- Reginal D KingPromoter
- Kautzman TamiPromoter
- Kim GreinerDirector
- Jeffrey Houston GreinerExecutive Officer, Director
- Stacy Greiner ChamblissExecutive Officer
- Offering amount
- $30M
- Amount sold
- $2.2M
- Minimum investment
- $25K
- Finders' fees
- $1.2M
- Proceeds to insiders
- $1.2M
- Placement agents
- Morpheus Securities LLC, Independent Investment Bankers, Corp
- First sale
- Nov 2014
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06c
▶$2.7MraisedJan 2014 · 15 investors · Other Health CareRule 506(c)
▶$2.7MraisedJan 2014 · 15 investors · Other Health Care
Rule 506(c)Officers, directors & promoters on the filing
- Stacy O'Connell GreinerExecutive Officer
- Kim Elizabeth GreinerDirector
- Jeffrey Houston GreinerExecutive Officer, Director
- Offering amount
- $4M
- Amount sold
- $2.7M
- Minimum investment
- $50K
- First sale
- Oct 2013
- Incorporated
- Corporation, California, 2011
- Federal exemptions
- 05, 06c, 4a5
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 1
by search overlapCompanies competing with Valencia Technologies for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Valencia Technologies do?
- Valencia Technologies is a neuromodulation company that makes eCoin, an FDA-approved coin-sized tibial nerve implant for treating Urge Urinary Incontinence. The leadless neurostimulator is placed under the skin near the ankle in a minimally invasive procedure to provide drug-free bladder control therapy for patients.
- Who founded Valencia Technologies?
- Valencia Technologies was founded by Jeff Greiner in 2014.
- Who are Valencia Technologies's investors?
- Valencia Technologies's investors include Inspire Global Ventures.
- How much funding has Valencia Technologies raised?
- Valencia Technologies has disclosed $54.1M raised across 9 rounds.
- Where is Valencia Technologies headquartered?
- Valencia Technologies is headquartered in Valencia, US.